Selective antitumor effect of novel protease-mediated photodynamic agent

Cancer Research

Volumn 66, Issue 14, 2006, Pages 7225-7229

  Choi, Yongdoo ^a   Weissleder, Ralph ^a   Tung, Ching Hsuan ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORIN E6; MACROGOL; MONOMETHOXY POLYETHYLENE GLYCOL; PHOTOSENSITIZING AGENT; POLY DEXTRO LYSINE; POLYLYSINE; PROTEINASE; SINGLET OXYGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; COMPLEX FORMATION; CONJUGATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG PENETRATION; DRUG RELEASE; ENZYME ACTIVATION; FEMALE; FIBROSARCOMA; FLUORESCENCE; MACROMOLECULE; MOUSE; NONHUMAN; PHOTOCHEMICAL QUENCHING; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; TUMOR GROWTH;

ANIMALS; BIOTRANSFORMATION; CATHEPSIN B; FEMALE; FIBROSARCOMA; HUMANS; MICE; MICE, NUDE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 33746903467     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-0448     Document Type: Article

References (22)

1. MacDonald IJ, Dougherty TJ. Basic principles of photodynamic therapy. J Porphyrins Phthalocyanines 2001;5:105-29.
2. Keppler D, Sameni M, Moin K, Mikkelsen T, Diglio CA, Sloane BF. Tumor progression and angiogenesis: cathepsin B & Co. Biochem Cell Biol 1996;74:799-810.
3. Kim J, Yu W, Kovalski K, Ossowski L. Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay. Cell 1998;94:353-62.
4. Liaudet E, Derocq D, Rochefort H, Garcia M. Transfected cathepsin D stimulates high density cancer cell growth by inactivating secreted growth inhibitors. Cell Growth Differ 1995;6:1045-52.
5. Garcia M, Platet N, Liaudet E, et al. Biological and clinical significance of cathepsin D in breast cancer metastasis. Stem Cells 1996;14:642-50.
6. DeClerck YA, Mercurio AM, Stack MS, et al. Proteases, extracellular matrix, and cancer: a workshop of the path B study section. Am J Pathol 2004;164:1131-9.
7. Koblinski JE, Ahram M, Sloane BF. Unraveling the role of proteases in cancer. Clin Chim Acta 2000;291:113-35.
8. Lynch CC, Matrisian LM. Matrix metalloproteinases in tumor-host cell communication. Differentiation 2002;70:561-73.
9. Redmond RW, Land EJ, Truscott TG. Aggregation effects on the photophysical properties of porphyrins in relation to mechanisms involved in photodynamic therapy. Adv Exp Med Biol 1985;193:293-302.
10. Damoiseau X, Schuitmaker HJ, Lagerberg JW, Hoebeke M. Increase of the photosensitizing efficiency of the Bacteriochlorin a by liposome-incorporation. J Photochem Photobiol B 2001;60:50-60.
11. Hamblin MR, Miller JL, Rizvi I, Ortel B. Degree of substitution of chlorin e6 on charged poly-L-lysine chains affects their cellular uptake, localization and phototoxicity towards macrophages and cancer cells. J X-Ray Sci Technol 2002;10:139-52.
12. Weissleder R, Tung CH, Mahmood U, Bogdanov A, Jr. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol 1999;17:375-8.
13. Tung CH. Fluorescent peptide probes for in vivo diagnostic imaging. Biopolymers 2004;76:391-403.
14. Hartman PE, Hartman Z, Ault KT. Scavenging of singlet molecular oxygen by imidazole compounds: high and sustained activities of carboxy terminal histidine dipeptides and exceptional activity of imidazole-4-acetic acid. Photochem Photobiol 1990;51:59-66.
15. Tomayko MM, Reynolds CP. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol 1989;24:148-54.
16. Ntziachristos V, Schellenberger EA, Ripoll J, et al. Visualization of antitumor treatment by means of fluorescence molecular tomography with an Annexin V-Cy5.5 conjugate. Proc Natl Acad Sci U S A 2004;101:12294-9.
17. Graves EE, Weissleder R, Ntziachristos V. Fluorescence molecular imaging of small animal tumor models. Curr Mol Med 2004;4:419-30.
18. Yamamoto A, Kaji T, Tomoo K, et al. Crystallization and preliminary X-ray study of the cathepsin B complexed with CA074, a selective inhibitor. J Mol Biol 1992;227:942-4.
19. Hulkower KI, Butler CC, Linebaugh BE, et al. Fluorescent microplate assay for cancer cell-associated cathepsin B. Eur J Biochem 2000;267:4165-70.
20. Cavallo-Medved D, Sloane BF. Cell-surface cathepsin B: understanding its functional significance. Curr Top Dev Biol 2003;54:313-41.
21. Bogdanov AA, Jr., Martin C, Bogdanova AV, Brady TJ, Weissleder R. An adduct of cis-diamminedichloroplatinum(II) and poly(ethylene glycol)poly(L-lysine)-succinate: synthesis and cytotoxic properties. Bioconjug Chem 1996;7:144-9.
22. Satchi-Fainaro R, Puder M, Davies JW, et al. Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470. Nat Med 2004;10:255-61.